I think that's optimistic.
Let's say they start Jan/Feb 2016. I can't imagine they'd be able to crunch through even a small, quick trial in less than six months, in fact I'd say 6 months is impossibly optimistic, more like 9 months to a year. Then they've got to go through the FDA process and it seems to take 6 months to make anything happen there. If they get to Ph III in 2016 I'd be impressed. Given we know the trials will be sequential, I really can't see Ph III starting in 1H 2016. I would be very happy to be wrong.
Timelines., page-24
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$16.71 |
Change
-0.590(3.41%) |
Mkt cap ! $2.135B | |||
| Open | High | Low | Value | Volume |
| $17.50 | $17.55 | $16.57 | $10.01M | 594.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 598 | $16.70 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $16.87 | 1676 | 1 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| NEU (ASX) Chart |